Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Erlotinib-induced pustular eruption.

F Cusano¹, G Ferrara, E Barletta

¹Unit of Dermatology, G. Rummo Hospital, Benevento, Italy. francesco.cusano2@tin.it

Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia

|February 17, 2009

Summary

This summary is machine-generated.

Related Concept Videos

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The effect of pollutant exposure on cough in progressive pulmonary fibrosis.

IJTLD open·2025

Same author

Exposure to selected pathogens in wild mammals from a rescue and rehabilitation center in southern Italy.

One health (Amsterdam, Netherlands)·2025

Same author

Quality of life after ICU: 1-year follow-up in patients with and without COVID.

Journal of anesthesia, analgesia and critical care·2025

Same author

Serological and molecular survey of Q fever in the dog population of the Campania region, southern Italy.

Acta tropica·2024

Same author

The clinical impact of heart failure with preserved ejection fraction in interstitial lung diseases.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024

Same author

Detection of anti-HEV antibodies but no molecular positivity in dogs in the Campania region, southern Italy.

One health (Amsterdam, Netherlands)·2024

Same journal

Correction to: Autoinflammatory diseases: why they should matter to the dermatologist.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2021

Same journal

Correction to: Actinic keratoses: when and how to treat a single lesion.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2021

Same journal

Correction to: Thick melanoma in Tuscany.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2021

Same journal

Spastic quadriplegia following intradermal use of hydrogen peroxide in the tardive curettage procedure for the treatment of a giant congenital nevus.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2021

Same journal

Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2020

Same journal

Cutaneous manifestations in an Italian military COVID hub.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2020

See all related articles

Erlotinib, an epidermal growth factor receptor (EGFR) inhibitor, improves outcomes for non-small cell lung cancer (NSCLC). However, it can cause skin rash, which may correlate with treatment effectiveness.

Area of Science:

Oncology
Dermatology
Pharmacology

Background:

The epidermal growth factor receptor (EGFR) inhibitor erlotinib demonstrates significant efficacy in treating locally advanced or metastatic non-small cell lung carcinoma (NSCLC).
Erlotinib therapy is associated with frequent cutaneous side effects, most commonly a follicular acneiform eruption.

Observation:

A positive correlation has been observed between the severity of the rash and the objective tumor response in patients treated with erlotinib.
This observed correlation highlights the clinical significance of monitoring and understanding treatment-related dermatologic adverse events.

Findings:

Erlotinib significantly improves overall survival, time to progression, and cancer-related symptoms in NSCLC patients.
The development of a rash is a common side effect of erlotinib treatment, potentially indicating a positive treatment response.

Related Experiment Videos

Implications:

Dermatologists must be able to accurately distinguish erlotinib-induced rash from other cutaneous conditions with different prognoses and management requirements.
Early and accurate diagnosis of treatment-related rashes is crucial for optimizing patient care and treatment outcomes in NSCLC patients receiving EGFR inhibitors.